WHY NOT DRUG RX FOR JCT?

被引:0
作者
D.H.Johnson
机构
[1] Department of Ophthalmology
[2] MN
[3] Mayo Clinic
[4] USA
关键词
IOP; by; of; in; WHY NOT DRUG RX FOR JCT; or;
D O I
暂无
中图分类号
R770.5 [];
学科分类号
100212 ;
摘要
Any therapy which effectively lowers intraocular pressure in glaucoma is worthwhile, whether it addresses the actual patho-physiologic cause or simply lowers IOP by other means. Although gene-specific or molecular-specific therapies would be ideal, in reality numerous conditions lead to the final common pathway of elevated IOP. A general approach to lowering IOP
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [31] In-hospital reperfusion and secondary preventive drug therapy for ST-segment elevation myocardial infarction patients in Provincial, City and County Hospitals of China
    杨进钢
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (02) : 100 - 101
  • [34] Drug Deslgn Based on Chinese Traditional Medicine
    徐筱杰
    Chinese Journal of Integrative Medicine, 2003, (02) : 135 - 135
  • [35] In silico Drug interaction studies on HIV Integrase
    Pinnamaneni, Rajasekhar
    Tanneru, Pravallika
    Vaddavalli, Navya
    Tatineni, Jahnavi
    Tharani, Reddy
    JOURNAL OF BIOCHEMICAL TECHNOLOGY, 2019, 10 (03) : 34 - 39
  • [36] WHY NOT LASER TO SC AB INTERO? ELT: EXCIMER LASER TRABECULOSTO- MY
    M.S.Berlin
    国际眼科杂志, 2003, (01) : 113 - 113
  • [38] AB EXTERNO DRUG DELIVERY TO SCHLEMM'S CANAL
    P.Challa
    Y.Wang
    C.W.Lin
    F.Yuan
    D.L.Epstein
    国际眼科杂志, 2003, (01) : 62 - 63
  • [39] Drug Delivery by Contact Lens in Spontaneously Glaucomatous Dogs
    Peng, Cheng-Chun
    Ben-Shlomo, Anna
    Mackay, Edward O.
    Plummer, Caryn E.
    Chauhan, Anuj
    CURRENT EYE RESEARCH, 2012, 37 (03) : 204 - 211
  • [40] Prioritising genetic findings for drug target identification and validation
    Hukerikar, Nikita
    Hingorani, Aroon D.
    Asselbergs, Folkert W.
    Finan, Chris
    Schmidt, Amand F.
    ATHEROSCLEROSIS, 2024, 390